}VJ/kwPt%Alb8@Ll,m,)@5ݪ4ز3, zꚺ%R7Y[/^T+-YtА֮$k̕tKl;%TKw5Y4S-+bfZU֓MͮmLs u&le4j@UӍtfl{$$y> jru9oyW?uuZ`,"KcĆZ1:Dѻ#= $Ă~P4*oMp gˣ=< 5٩=]Ө;V|,ѾXNl'H{iMu! FU\YZبq*ͦ5=Gjֱr.PlĻl^W:pyS黎ՇRJ]SYJԬ-҂+z#Aa㣝R%ؓH|aȢEVC@;m)9]S1kAN&D+,,@QPH ca!P AZM-B P!etO^X0 'ل]ٚs<9^w~}Zm'K3xêy9Lm_Hnc_Nv(AVE-秚FOcB$aNӵR蘢xvZ|[r/]ںvA7ф0 k&@۹akQ@aXpa!,>䂮+ZN:aӈ;n4X#V eQR&ݛAWI3 idڰwz ;˳Ú,&5w0h#mUS݄ ?jaE;;D}6uJXͱX  ]zM4* PwDm_ K0L]2:m*$ף4@sH:}KMSL2lt+r,[j|j\Q!&F! [j:隌`rtPB$-DrT+Sqd)>JB,Qba˃CQ *yMG:lYAS HP@lVj7)S3y~YZ)&qeyUԃ@j bf&dzF=TdQnVD*W۴z ߂@Z?~K*AƍG*59 |Υ:Tڸhi,=\^E 0%O& ps U4'P%-ZGEJ09@EJ.(,@@+TTЂmB-B&)g\ua6njKk G'VUU:5\mq}Z"6h(?g*K @ !7pkIj>@ HT PoXءj fdRx~Kz٩s~^l&XHk\„AFȌ ؍$iZb#j` JZoa'ZS۹z,Q++'5EtX\ j@9{1DTI[ܻOkAӏe5&TKM pN`J€Me00BFW 6<|N{Gs~UB=Ά9Pk|B z fSf))ɠ%=k1ct;cMLD(WEBqTaQu}b0g-&wD-] 3bpTԠ`i~ ,ExTB%J2UBߧd3'VL]J@[i|0 .Լ^Z:.KS1:Rj@6$?uvME7|!kGKB߄&dX$j' #8d@.v1~W 'rLQmS`贄GBbĴQ*l`fA#Cq|} Z-oͷY׸/eX ): *1c9U[Kˏ0Gq(%#dA Xna\USԀ$6a4SrK%QSŀ5P"m#`7Ŋs++ <휘gD򛰉 7`1b8 }Ȋ(!a;YԎmgHЄD5'lMS&5SU4H)7IJSN9pCr8* T9BiX{)8iwWӛ>Wk~f\5Z3\."uhHpmӄ,DUV.xEQ#-d EIsU,cEf_e™B`w"й032F`DIBMbxhxs gf5Qۯ4n V茈eeI !:QJ촘35Ը2f?T/=h]ظb@XGP# _agLkvۦPM?,$5Wl1 2͖j#Œ&2g@C=❪Y!Z@Үkln\qX^^^%<ĉn;z||u(lZ(N ܤE1/P@\=ȕl^ (K;j8GL(~b̐-4&qC`|/S8Zr2h[̨9۞qKlhjz1C\FgmWف/s z˟Z WG0`1 4R *ˌAJ)OjC|ĕ*WmΆ'0r~!Xᾷp ^ i823>thyh)M#VCAzZPY Z|41s#^=68H=rxQL *b蓼o,jIJ*zMZٷUySC,4D 'g- aXCfliYZBN%q(,{,h'J{╕1D*S[c],;-]`8=p?]j\ʴǎZkG&ٜ(<4H"12<;a2Fٖ؎*rSTSt!ʆ \c nD^$**ʎs<Rd?xHn'bA1j0": . FHQ̎ " P;S!UNH]bXcF`rmHW9"gt<2Q>h.xXգ:ST(bYxGf=6GlQN5PqYj'|4FMg6$Ey+ŖbL vݙ =UBxu<*hK=dgO:gMS,:Tje1'jco /$( ֩[r%]Y9>_h[o0H+k$Cktk枆}HΆ%ڼ^+(!@k5tH@A92)W:T 8 MY!_tiT' MϮ\0;`MOj 2ũ, AgB@$"d~4L>aGt%|Y$tr?yԍگ^ W}f 8 BZMg݋x)-K p7j):: .כnތ[~[CNmye" xrwe]@< Ȍwh&U6QBBj#TƹhS>[tW8=Se3?YYV}, ͔h\>h\}lkԉ#|ݫ>+PIW1IKZCoh n\4_W7MwPݥ9@<%P*`e 5$/TK[FX5SitU k=#LCW5&"eVH<g1bO\kkY^fd07As ;¹ 9f؋e6А\&Ru;6.Xg{x<&?h4 SH(S /,$ ؔ07 e@9*ϣn\|^-ܨr]f)%l/]x][=H PViL! ݞ݃ӏMnE=_TcTTV!y{Fٹ&o(π5>@Az#Ε3x -C`眀熥=^JPzz+Hh2 :b`؝R_o̔k`?l  CV] sv|W3'P@slb'2>;kD0,`ّW99G(H$%rMH걙nWTv SAǀ@m!$lpFÐ*7U>*y{_t򂒺}r}aq}SGtL_}Ml= t VdD)>~w]K(b ֞l,γS:+ T'.K& AܾrPsN`Kx[K#~Iq#@_"ljtJزR( u4``3-";,YzKD; =q~]dűbC&cB[ BM6l_u=®~KE.rk6 k9NY*lQ]t,jA†fY=# 1B`Y`5'VșFDPGJnF!YtVjr,sD{@ 9h-'.0.=Чj h۰Yb$hdXT tvP`De.N\ <%I9!#4x0uz%fC,V-W@)lx?1{5HJ_ OLd> FTCzK7t;C< <*,㪔w2˸a&˿^YƵRÿ=.,Zud%)a)߯P*%$OZy0kc958Ojc558wM 1 ب X^)顁DdF#m^0ݠD?z/ah-kS5A!7@k*0Zi4cENki=?q^ַjRE~^vO5A|3u:ϡsLTw|x[_!; b_Ϻvp;FX]]=`ԭ4{v9*Y`9PlBPTΖl86s|88K}r9ힶn:f{_O3:]9aXXi|˝n|'{qn],io/v>{J[~}ɸDNV6.݃Kty]~ۅ:`kd1ozqyNH~9rrZ@/JzY+:v?|g'w+ݛr˒q.JBP+ɇR[pwwKKewSr\_;WooV?~?9+oNʗ_J~oO?G6P\4.֏nyzͩ^;;j?픺fmRku7>ݽ|]-5>vwGe|}p/E?\k.w=}t ӿ|yXm/3G.VZ~ov_}mZ*]tƻ!(JzSn|y~PY`_jK;}c~<`ݵzCQ~p?׿Xߴt- A9uWWyiyu9]}/%fsؿTt~SZNZXoig%S7QtzWͷ{kՏ-6;wd󲷶/ߓ_ooo{޽_o|Yݬ[_-QS>}Y+ .ti{GG+GwjX[z~8=rcwӿQYOu\qvwNȷiwm6NO٧߽;8=qWJsۇ!(ڗw.9\=suߖ޺g_ttbwumwa|Щ.vH[#~/W _](tLH?Rh;Jג>YNiÛii/<Ն OjⱲ*g)UY V;[Ig9acElcq)K9 8/<*?^t2^%vOkӵAvlygf˴`P횆>>JWכ4& +EzRYo:j^0q[`V C ܊ QT奇f{doRb>rLqsY(jf6S-, PxjŢÛ.fp0 hWm4(? vIa%' /x (%9ew7u; *e?Sx^ z\[$JP{Ȕ"Yz$><7["EŰuhe4(r?("tHFtFڒj5I-3+iQi[K4D"gDuhhQ`RT{q3ʳ/dC!!7ʔV4PbrKqQ"wrIrϛ1A"FDӢmY%S[3S15&FHxP.~⬌Q$xw.L@@v"J NMb4E I0 0b2@t126ߪG~Tӻ*a]S-c %#=o: PXd"ܙA $J:x.mc5~D91[eTڷ9b*+sPuz} mX >05~X 3HWm<3"oG";bfv]6m7 $ͪc~|vHؕ%5YLZ9::i}vXha>A>φ5fI8R|4 [ ;lL|*"0'~T诸1W#а|4"hՌVn&&vDcM1k+"' QYlbey?F&ZCDL<$c@RXJhGa.L0#U7DyN|a7%&s@'UE@ vر2 ZEZa8&ȃtNG:a 26WW^vV}d3Ά8I$:xa.PMݤ*3֋Q*1DYc")riJ-LR:j:3-W@:d1g9>xNx6=bD28xyAԄ[#,!Z:(8bϓ ?;})0,Z%aIٰb9_+1H8w~r 8yz-@\Z/&Ɵ˧!/G7TlPgG?xR;/⸀q0;#oy!~~xs~ph/NN؄mT|*=jm m jZzNqЖ/ցQ[Z.%#A=GEnyŭcHFO$oSJ=܁`̎I LDSJ,✐bA'L8d*- +T1 ' gU푆hIBf 4J2 9v(8Z`qT &Zl5}0E / iiJK$HKک ~D)&zQǡ24^9*F6a̱x .eʼ왇 A\_eY JTLQX&5L#3cԲ$\Xk V) I gf1V%inJ{M gڝ_t%lUPrFHGt(x<;kw͸gA"6-ׂ'ASML 3]d}('IaEړ>i*T,tlZی}\bht})BY/z!=%Umݓ&U=#rSE "f[@b~?fŏ) *lB6bv vCQ:7唪6 롍=Ztٙ8%ac3!0 55ϚtZ/`Mр]< =d@eAt8G7fbrw[iOp;4a7պv҂tt3Ngi;m0.Pjes Q9E4`+U ꗠϩa,tH+C`S͖ft@^8n|6K<@0ݭ6l4X_TQdᙽJRJzV$=GͿF`Vu1U[2sḆ'H! K9bˆbaL{RfFq91&`mqHF;44Oc=vw?:qx9Vv1X7t^zܬ޸88~{Ry\Jwд6-,s>_&V7Ϧ{JOgo0(lrμ AK%$1. i}3r6%e)+켋.$.}H|QR22IBb׋Gak4vT_01f'{:>px)N=NRLK,L4YGGdA#d |dQ[=*КC2b}l Vdc118dQ}?FltC,] =t`G]̀1]-yp~QLEڬșݶqMcx=vQx}pDf\k&AB2^{TQ_j.\B>ԜZaE]$Ur8;\L'1΋*Z;v`iJI)I wRURˤ\\vt'*Kn[zK=|v'vRF᎖_GwEZt8<N)'I^J܇mKY[w8GyswC5 5)Yl'+\$;jh-l_ʔ& MH:Aґ~Ӿn2@d:2(SCoC zQ^O0$:582 ߇ [; |7ɽa M }ڠR:Q)7R/%,l0f=qZ zi?A5VE # y>hm|L>>?V-9FKd]'4QbB=( Fǝeu#SHx)NRgi5/[x2i"s'OJ .l?PyDڇ~^<2K[%mra=yA&s (SFtkJtiY}`!5O.vgGϝs=Գ|iIH%~x5_L21q 4VVN;fɠ37uC, h4kwiHc ݙ( }};#uHFy=:,n-e3 lu=@; Q.0B "'/xdJ'#QFFE}"H6_*Zb'_pDvL"d$-Dn $  $ Lnl @{jhXMHsp;!rax&h[ZҌp ?`J!,J!]F>TML1TǥYCCL w6(%~涅}vqJXpzZw6/~UF${YD5G4B( I\R$M6 OG}Iu~gK[RgsP'Lz* HYM_7>0٣?D NNbsO,KmK kmZBL>EU2[i/i)czn}N}86jƝk@ުDumk4 DM:DS8ݸR$%HpӞԊzfa-\5Ƅ۱gSmvd-Oluh}Y ''Zp53 P+ II6iz'n.F(d`D]7ɟmEL{F{x"{1Luv,*uy%ߒH;;L`Qn `-?3:::::::;1kuuuRyyT+}n7T/y72:::::: c[5w[[[[huuuuu5g(,l5z4[,jwoPtoLi|gɀ/ƏӪ $_TߞOM<+5 A{ts#& WF}ғbg{ |0nK gigqQJM ] [Ovv*'V~V3EN38SkF{IIvAe&r@ QIM>S9"sMSl/_UD"$Ula1*AÙVVO M9MS(#kt CxEZa ~`v5C^uX+?F6U*"+;E\q69Tŀ҉^đ)Ea8B7i*0Ag *1D͐u)riY%xP`PYWMy fbr.}U{DJ=-4=tQ/Pg.[O8zuy Ԋ=O&x7iKH'0!`ByV +s*UcLË=ON:k9n5,8.Vj|gEB0s`6UƛF~qzvR&@l#p+OɶR`3mLFܾZFmi܎^g>B!?"N/w <cC xs_0 2e{x)BP9V݌O8UNieZ&4#RDz?AL6BEϼC#0am\6"i &8=y?=׎EE ;t l⛓;ӈmfy.A/46$DI?3B.y*촰'ޣa/J(v)KfmL[s[НbllZQfWM4(@qkk.kTZ".Z a.̞G\ mWzvێ)#P'Qg#K N !㰺G-#x;, ~&Kof6)H\FB x0<iS46G3X&sn~?pZ~WޓЎoq^8z GHn5h+zn'<2r|qFGBHgux#me}#zqL=i)Ed來S50XN r-MQMk= e_d 0}MN ) YDpq r<4|K*-(A*3¦is20t:r%-ƺ-49^aE}ipcc>I,[zoLr3Nl(c|`tf1T|h:Ü>B_pOP˲_GDYc}Wݟ?s_^N}Yr.πc(>.DgD'ү/>pYWg0سׯ :i~mXЙ{ABg鏄 i># Crt!,m^YaNzw/K"#Oo1N,a`g!3'm9 7H FD QG mB"ZqDe=cv#̎~鄥EWKgg!9DlJ|&]eY0G?;4=rxۭXKǚ[{<)-ΊYm`|PW!6&)0Ǻe$t=#8 7mio=ݙ+. Yҏ,CW~ug[,0x fZ'|en b;?h(QRG BfI꿜t/쵒\cLi/XKriYjGې]EZ1+*{v^gcrA!Mm-ABV߿<~`}7X?}FL-l,}Y;\_Z8 @@˔Pa(Lقt:(>,FP+S`37[]`̕[8;wDE%'6cov[J3X'pBF m'F .sҽ!L)#O#ܞU-ZY*߀г:(,1?MhG T}Pr޻HKS CCMJoFo]y~KvhV~>ZWvtfTmT4$ Z︎4Hνk6@WUy鏠"ÿGoÿvg>LQAY{mx Ƕu1ۏ}~?hK;7cU=sr&=߄kݮ?vuEnԉѓ{-^[~\у$@# {?uǾE}lAz߳?dfG@ yڎ>΍sS8.=k:L8+K vt"z;0i3i !v7QEDITORIAL -->

EDITORIAL

Vitamin E Supplements: Good in Theory, but Is the Theory Good?

E. Robert Greenberg, MD

Ann Intern Med. 2005;142:000-000.

Much of the U.S. public has a deep, and seemingly unshakable, faith in the health benefits of nutritional supplements (1). Use of these products has increased so rapidly in recent years that a third of all adults, and half of those older than 55 years of age, report taking at least 1 supplement daily (2). The shelves of pharmacies, grocery stores, and "nutrition centers" are well stocked with a dazzling variety of nutritional supplements, and for sound business reasons; supplements accounted for an estimated $18.8 billion in sales in the United States in 2003 alone (3). Many of these supplements are promoted to the public as "antioxidants," a fuzzily defined category that includes vitamins C and E, some carotenoids, and many other phytochemicals and plant extracts. Vitamin E is the most widely used of the individual products, and it is taken daily as a specific supplement (usually containing 400 IU of -tocopherol) by 22% of U.S. adults older than 55 years of age (2).

The touted benefit of antioxidants is prevention of the major chronic diseases that affect modern adults. Belief in the preventive value of antioxidants rests largely on 2 bodies of evidence. The first is epidemiologic observation, which has been interpreted as showing a decreased risk for disease among persons who consume relatively greater amounts of antioxidants in their diets or as supplements (4). The second is laboratory experiment, which has implicated oxidative chemical processes in the pathogenesis of such conditions including as atherosclerotic cardiovascular disease, cancer, neurodegenerative diseases, and chronic lung disease (5, 6). Clinical trials of antioxidant supplements have not shown a clear benefit from taking these agents. Nevertheless, they continue to be widely used, even by physicians (7, 8). Many doctors may share the view of a cardiology researcher who told me his reason for taking vitamin E: It won't hurt and might help, so why not take it?

But could antioxidant supplements actually be harmful? Two large clinical trials reported in the 1990s showed a statistically significant increase in risk for death among participants (mostly men with a history of heavy smoking) who received -carotene, an agent previously thought to be nearly free of serious toxicity (9, 10). More recently, the authors of a meta-analysis of clinical trials of antioxidant supplements and gastrointestinal cancer concluded that random assignment to supplements may have increased overall mortality (11). And now, in this issue, Miller and colleagues (12) report the results of a carefully conducted meta-analysis of clinical trials of vitamin E supplementation. They conclude that high doses of this agent increase the risk for death. Their meta-analysis involved data from 19 randomized trials, which recorded 12 504 deaths. Overall, being randomly assigned to receive vitamin E had no effect, either positive or negative. However, the data suggested a decreased risk for death associated with vitamin E in trials that used lower doses (<400 IU) and showed a statistically significant trend toward increased risk at doses of 400 IU and above.

The finding of possible harm with higher doses of vitamin E is surprising and has serious implications for the tens of millions of people who regularly use vitamin E supplements. Yet, how firm is the conclusion that the risk for death is increased? The wide range of vitamin E doses used in the various trials and the large number of study participants and deaths enabled detection of possible dose-related health effects that any single study could not identify and previous reports from meta-analyses have not addressed. Although Miller and colleagues excluded 17 trials from their meta-analysis, all were relatively small studies, and I doubt that inclusion of their data would have materially altered the principal conclusions of the report. However, I am not totally convinced that the authors have isolated the effects of vitamin E from those of other supplements, since 10 of the 19 trials included in the meta-analysis involved provision of vitamin E together with other nutritional supplements. Of particular concern, most of the evidence for an elevated mortality risk at high doses of vitamin E comes from 2 trials (13, 14) that administered vitamin E together with -carotene, a supplement previously associated with an increased risk for death. Miller and colleagues controlled for the possible effect of other supplements (apparently considered together, not as separate agents). Likewise, much of the data on low doses of vitamin E comes from trials (15, 16) of multiple vitamin and mineral supplements in Chinese populations whose nutritional status and causes of mortality differed profoundly from those of the North American and European participants in the other trials. Miller and colleagues acknowledge the difficulty of drawing broad inferences based on results from poorly nourished populations. Nevertheless, one cannot fully discount the possibility that the effects of specific supplements, nutritional status, or the conjoint effects of these factors underlie at least part of the dose--response relationship observed between vitamin E and mortality. Thus, while Miller and colleagues' report provides intriguing evidence suggesting that higher doses of vitamin E cause death, the case is not ironclad.

The lack of a benefit associated with vitamin E supplements in this meta-analysis accords with the published results of individual trials and previous meta-analyses. Despite my uncertainty about the finding of harm in this meta-analysis, I fully agree with the authors' conclusion that high-dose vitamin E supplementation is unjustified. Ample evidence indicates that taking high-dose vitamin E in later adult life (when most use of vitamins currently occurs) has no favorable health effects, and Miller and colleagues' meta-analysis raises the possibility of harm. Thus, our message to the public must be clear on this point: Vitamin E supplements won't help, and might harm, so save your money. However, many users of nutritional supplements report that they would continue to take the supplements even if they were shown to be ineffective in scientific clinical studies (1), so basing our advice simply on evidence of no benefit may not have much immediate effect.

The public's faith in vitamin E, and in antioxidants generally, reflects the strong belief of scientists and health professionals in the theory that exogenous antioxidants prevent chronic diseases. Ten years have passed since publication of the first large trial showing that vitamin E supplementation had no effect in preventing cancer and cardiovascular disease (9), and subsequent trials have repeatedly confirmed this result. The story is similar for other presumed antioxidants, such as -carotene and vitamin C. Yet the notion that consumption of antioxidants in diet and supplements can prevent disease appears to have drawn strength, rather than been weakened, by contrary results from clinical trials. Investigators have called attention to isolated findings of possible antioxidant benefits for subgroups of trial participants, or for secondary end points, when the overall results of a trial were clearly null. After -carotene, initially viewed as an extremely potent antioxidant, was shown to be harmful in clinical trials (9, 10), some scientists opined that the result represented a pro-oxidant property of the agent under certain conditions; thus, they made the seemingly perverse outcome fit the antioxidant theory. Meanwhile, research based on the antioxidant theory continues apace; a recent search of the 2004 National Institutes of Health funding database produced more than 700 hits for the term antioxidant. Most funded studies are basic research, but they include many clinical trials testing vitamin E supplements in tens of thousands of patients, with dosages ranging from 400 to 2000 IU/d, for prevention of a variety of conditions such as dementia, heart disease, and prostate cancer. These research projects have all passed a rigorous peer review, and I do not question the scientific merit of any one of them. But isn't it past the time for the scientific and public health communities to loosen their ties to a theory that lacks predictive ability for human disease?

Author and Article Information

From Dartmouth Medical School, Hanover, NH 03755-1404.

Disclosure: The author led the research group that conducted one of the trials whose data are included in Miller and colleagues' meta-analysis, and provided the unpublished data to the authors of that report.

Potential Financial Conflicts of Interest: None disclosed.

Current Author Address: E. Robert Greenberg, MD, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North M4-B402, Seattle, WA 98109-1024; e-mail, E.Robert.Greenberg@dartmouth.edu.

References

1. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans' views on the use and regulation of dietary supplements. Arch Intern Med. 2001;161:805-10. [PMID: 11268222]

2. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004;104:942-50. [PMID: 15175592]

3. Supplement Business Report. Nutrition Business Journal. San Diego, CA; 2003.

4. Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr. 2004;7:407-22. [PMID: 15153272]

5. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239-47. [PMID: 11089981]

6. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239-67. [PMID: 14744246]

7. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med. 2002;162:1472-6. [PMID: 12090883]

8. Frank E, Bendich A, Denniston M. Use of vitamin-mineral supplements by female physicians in the United States. Am J Clin Nutr. 2000;72:969-75. [PMID: 11010939]

9. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-35. [PMID: 8127329]

10. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-5. [PMID: 8602180]

11. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004;364:1219-28. [PMID: 15464182]

12. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LA, Guallar E. Meta-analysis: high-dosage vitamin e supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:000-000.

13. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33. [PMID: 12114037]

14. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-52. [PMID: 11594943]

15. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483-92. [PMID: 8360931]

16. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:1492-8. [PMID: 8360932]

}VJ/kwPt%Alb8CBfyRȒ"SqVM=}R]]]SW޾6=Djmkתzc6$+-s%|"ێzC $`?gM,nVdyKz؆ٸUըx3>E4;E{S\C̀ [) %Pd#-[6 4IoiO eU٭_˪]-0%ݱbC 1D[&= $Ă~ӺK2=6^l1C+Olr4x5ha6+}4/E< +'Ƞ,olԵ5XZdEs]ȂQ:nY.V76Jis\Jf{5'JcX9(B]2f62r}jT@~i3mN,+x6k`ƾH>)V>LI$>0dѢ\ GWm6/:/l:oI"v3hm:Yݍs y(o&#>bE,br` N #"g JŬ7b9&5IpvFoXZӗ9ZP(Ć Wy] @ ]9RQBl>/ciwxZYheK[|wU+ŲoIOul{}&Y4Rt7 EN/nE)3e; A&he4i5apǍ+*,JJtѤ$ۑ40fI {MtryvXYeڤBm}ReT7al;ZmX){F'FᭁoMҩptQy]T,{ ]zA4*sPwDm_ $\U_VA .FZY*2k ph`P5dV` ~˻`:n^; кr+E&(XP!5)il6xUl6Vga*&$4b+i0`Vg9/K<öMf۴Y@3np{0da7Gqw:l;#l\^|Meaedéw EhHF" i#]vR^t{h)];@ A|m"xv8Wlsr{_6D fD!9amqG!(q6D1Ro7p%ZUx|6:H#l=<(3Unh6:^K[3EUd{D RASu-*`H-[ SZߊm ~.3m ucnH!%tFuyQNif:C#4)6Q .f]=R7yW݉8Sv ڇTS\P.)S>(tO.yAL{sWHv%.I>~0tYrR#zӅA9DP;uMHdʊ+f&E=3 ]2!άV6&i4*_?Rx6Qn Yn;]LߴR99S  ˖9WTf˱QVpšNéMЈiV*:(E!`\BH82dBK$r!(İ(Jp<݈C39$( jcNVjf7)S3x~iZ)&qeyUԃ@M*1bbdzF=T6dQVD&W۴o ߜ@Z?~ŋ+AF*-9 |$:Tڸhi,=\^E 0!O ps U4P%-ZGEJ09@EF.(,?G@+TTЂmB-B&)cܴ`njK8ٮfQmMG5.,Љ-`j|QL`*Ë[ka2\lJAVs B5(KU,:0&l _?vUQەN@ Gck ~Z]5/r" ,0ʰ1Q2 1u@0<)ho@ Of)'9|e/n$2T ہ0 , CCm ?!lQ2DJA0Om Ja.EF+Q v }pOrg[TGVUiVpQRƭ_I;<96/+Ml/tAݤ\S&ͥ b@PքxR7UK0#?l ^ҋ NJ?b7B"|]&|2DfTn$NRn5Q׀bPW mКȼkJQ9-"6cpZr EΩ@HDyC0M8 D5'AoR>>jK=@2M*:A;y86RT2CEr;;8m@*m73Gʊ*M2?Z ?D5Ay퍌WhwaqvȠ9֩n1JCSNAW6f4ʺZPpgriBL5끣 z) _,I禍˯ ޚ^-ChvWa|= J"Τr=_YqΧ5LÌBm8'H0%FꝀ5f00U\Jⵗ#6,|Ns&ʄ.Ш6Hx!/zNu v2 !zYzZﭵ Q:Ѐb݊,,G!j7B"ؖT#[%ʆ>{Gs~UB=ΆS=V ٲ)s:6̦̞SAi h&Jrdcw`ř QgQ.ˋ h ģB`ZJ@,gf'!!©| gi~ ,ExTB%DJ2UB@fFL]J@[i|0 .T^Z:.KS1 9Cv= B60aI# +KmX<֯YCy o Ch{dd% kؠ>n\qX^^^<ĉn;|||t(lZ(N ܤy1/C\5l^ (k;l8GO(~l̐.5&qC`|S8J|2h[̨9۞qlhjz1C\Fgmف/s z˟Z Wf0`똆Tle٠YO'{̀\5z@!>IwgH?p[~8l4imx]:ICU4 =r;h)w@sk61F 珕C]TdjM$cŘ]!, ! #t _꜠O ۉ,xPwk !)%ٴAQ{6;T{3o1Dr%:\GDL+KnC>4}(;VaGt)%|)Y$tr?yԍ/ nW}j 8 ICZ݋x)-K p7j)::-=o7Խ #6@1-$CzCʂ}CofigO@dgeYaIS04S:qq-RǎAv/q*K @1'Q([$!.iI ^-i-n,b51K "rʁ%%xJ·,T.jH_)7ɉ׶x-W3 =*rѫzG46n[ M:QE:~ Wd?Z%x> |<3OuG8Lsa@nGtws9[atsN;dBC|KQleS]=BxD  2\aЌAnۊD#!o0U #йTO -r!sP Z(خq e4[g3k„ ̧ѡXbA@r:Us`PמYU`HrbCL #/ w_@ 6=Pvd D·f6Ӹ Xȍ XX0S(sp7шF\7Z%b6@wXSxH'7&1Pb7Qn/k ZoF~bW £b+x!u`P#ͭD+@)\eX쀤rKA5LPU.q w. 3ؕ ]/..bT$z3xG||$=VTV+W{i _,Ǫa{*NC?Biΐi"҂.,d'Zv "g(1coEE\tOUc3oN T 4u3Ɗ1Ǹc,5NvI%PLaEyv"Ut%aڅq|!:(7jαl1p {q/1:nk@ĝJ12X[[RR%eYYa3 "[Ec'%KrasuT:'o8V bx B(x/[ȆGoQlzƏ@3w-c4<@&:"e_@5iUX6\7}NykE iNxb呸ɩhuA1fELoBO <NJyOhPC|Ak8鷀q`:} BKֱ|6oMbm]Hi9M[Ű#@zW5)#|D4q@@O,4uŪ:eU7Ր3U1EJiPN5tHIGē`xţnE,d붂D̞k4N< FҨ $1Vz]y"6 ޛ7 V͢U~f.d CU?^Öэ@kĩƵmЎhXJݝn)+.χ7JllʛGᗋ71ǫ9?~8:OBbṫmmMFJGUF;нDᕵʚ,I3,CA [0!h$^rݔcV oeQk>*,ZQa/3X\ÿX̣2R~X/kfze\+>b2uo_GXbqu_b@`)76im7V)4PY| li?~1 @HDfAb4 JsJ1q:>Q]rC z6Q"J+rRKk ,S{VJpcm?a*kEՇkPd}A}kw!LR[jf Ŧku}g<`I%_'V[uk9Y&T >=b}XgGz#8K^X]]=`*.L~y%r,+(-_o87%s߹|ptkQy=5kFׯk/NNsп:]n;Ʊ/7WAN@Hx:X_\ {~oS_q{'g^v{p./v;ͯ??Կ_8c 6 {Oa_w7ݸ>l~JPߝ_yV:˫^} U#d}rjڽ8-_KAӻ( A(]kKݝ~m3݃GdySr\T?{/NһuoNޕgw:?G6P\u/֏rm9 kJݩ^v8)OZWz Kեw}ZҴ?v7_~gի ӯ?~ٻ8V#gN>Z_?Zo{PRj֧BPUSF߭}w~.->۽Kmi5˃]i_Zzm}..eǚ/ʇΩd?D?\]]jyu9_㺸8Z.JwWGO;/VGj{K5@_#(E+ u{vR{l^ז:O]onck^/ݭ{y//Y(XnkAxz_ ;ڡ}ԫ<8Z9*~W.VW;/wߌ]tκg]q9!ۇw?=P (l~oo_?~<(}xuuz7jvAp|p>.9\}krߗ޻gkDiqiǦGt|sT˪|<(b+1@<—+~l h:QmZyvX3t|/ KUTm}c-&)@kI,M۴MM5ϗRjÄ'5XX][_3┪K~+-ҤČfxzk60θ{Rd9EhZl@/;' Zڠl;6욾Y7-3[a~kiܯ#?}-t9_=$z>j>>J74& oEzRZ+n>:j^0q{`VN C ܋ aTdWfyd ob>rLqsY(ffo6-, Pxjƛ.fhr0 hWm8-]g8vKYrl3wN?aMP;9-ŋub孡=ͳ:'`.zp.~ZqlkUVh:Gm-sԡGi7q/_dMC &t֠N|P~lJ4O=N_'2VQJ2BEnvTJ>/@H()A©?*B@1<⾏H5eNRVAQ2Y[JAVZO jexT'WdsYMo'//V*ʩ,(Xa(w0Ҿ,_3T]) ӖP m20W=نDnA:;#}dK#Vkh[v;DYr,/OS<KI+2;GGX#nUҺkm" G Ȑgcbٰl21Vod=awm:LE9f"o&FH>4,_3lo½Uۤƶ !Xy I&C=@bv5X{Oсt!"DQK sz$65УMW0aZx`i|V}Qު<'CL۱&v@'U@=B%Kmce>6pL#8t`=l+2Uɮ8ZJ' ph?8 G&MWOH^2>V!jCILN PbAf2T֩Uqiҁ8;>˹o}uuƳ#.Pa[ &a V6@G{LyKH'0!`׊{&Ê圊*c#bIocpo뀸 Ə_ԍ?^OC$b_L>j(5,٠Ύ~lj%w_$qs1} $`wBWGr$CvbV8=;cN QN>O-Ў-ޞaR7h9]vC[ھFeiߎ%?@巎!?M)rƒ1;&q0|HJ9!E&O`#C= pɲUR VcdyN~Oƕ# ,ђ (sui>drPLr dj1Qk*kim5VH͆dSIciU"Z#1Hdo(ńϡz<*8Tf+GE&9vIR˞yHx #+D)j|曞ibFr ZT:P"  {*4#6i ^4 <ă12XG? #I`p͔j3Rea "]PU AU7=,;2023a;}83QOZO@.< pU@W *]՗y"]ߋȣ! Ӭv׌zF0ě  A-xҺ4Ud0EZz߇rRY1;H1`JEN%FAח"4՚x ǞbSxRe@[198* dTd5^:gb1+)~LgVI|fB t٩6?ҹ//'TQXmt Тġ-  oa I~R}E6Gv-'L1tMl;h7NG~RxbbfLRV<#S>mr uG=,Zў S`YÎkX0 T\m`T.oц4*oU`t~%sj'%J#+8؄eMy&LwC62@dH;2(SCoC zQ\O0$<582 ߇ [; |7ja 5EAtT(n$,_?KX2R3#Ӌ0f =qZ zi?A5VE # y>hm|L>>?V-9FK꤁1 ؏i>ĘzچQ;5J G.6S j*_>d>X,Oh/2KO-~*T]$9{iG,mb?<6S˅= 4;Vf'F60^U[HNϪ;;{NSxzc<-VDOURI8n*J)z,榎{h jZ1 uv X``r{?p\_P"(/GEmLtFN@Cl0uUP#"e;glnDC,quP% HlZQ5z٨RK%<[k4@d h0/IqI@B& 45|ZH%V6o\ 4 \A_RlH*RHO6gSp3mSDL/B$Cqi`H![f?s[G>N ]ok3<}lty?)͋-_` =,٦rYH! %INk.xr Iw&G }R_R~æd;LP5azt(ؑcYWt›8#_Na"&&xiӑbo Ƌ)؀jyje_F(;hr Yu'Ls TqAsi&?2(}K"!S{Hs֞BӶ3`p2 zʭN~&zdҀS)"a+,&'0 ; _+_ꙗJ1 `wj]C?iM%dLQ ((Â6sƨ4*s5L#+L e?udzv,9 ؖz>xod}nd$89S1GTԣް6: ECjGIǤ[$ '6"4j^Vm0O͎%F}Y3B[١tJ>@ļd#uIRUnړZ;G3Ɵxd,{ 1v~T릝-YfӼ[Z|օ"I1:` 4 v|pޱFoa0`y*6>}ELZ6"&ʌ==C~q<Ľ^I;uoI[A0P0T7J„Xrslyy֟nnnnnnnn5:::ŕQ8X^CbrYzR|mv.ӄʉ)g=1LD jުmcP8 Ч!?CbRTHʪm"%BJ1=tQ/Pg[O(zuq Ԋ=O&x7iKH'0!`ByV+s*UcË=O_'c՝~ Na1TZ/˧!j/&G5l]|V+13"! ;xE0*Ij^zqzv&@l#p_m m gV}r! (M }zmoC2"E0^@x0f$/ xs_0 2e{x BP9V O8UNiɥZ&4%RDz?A6BECBN d6Qnk.J4eòI-oڱym;ywr?ئh'|KcnڡIN3!xN7 {ӎ"J7zE4Ӻt9<VTٕ>4kNlg!6^kK)>ZީڅxJN@sQ D0$l7>{ĘbT8 }2Aw?dV;jIӛM~ R?o>H^1) zv{X{< 4־ɜuئ5"V{CǕ=RWѠܱoh$Τ^Y(ɭmGF/8nH錿R/|$ /XZ#߫1ոzO,°i9utȵê4Y gmy5}38v=6*-d )F^0)ƻxsiDZja-T5¦is20t:rba sNiͰ>Lvxچ!ؘx.տ[ncЉM?pN:&MgGS T jYh4abaop[Ғ37g럹ߩo?K~5^OpJt+S.ڋϺ:}~m IkÂ/:L_2t^ j4 CT@a1Umh5˗_Ćd%=Ü^FEbűY!Cg O>r:EGo@3AX!?6%xkűcϖG) K.7KgCr??~M(/4`I~vhz[[ӱ5 uG8yRRq'sl>Bl`5Sasz#3U˚I{GpsK0o\Ez+. Y/,CW~ug[,JҸ(p@\|%*% =MP/tdv]k% Kh e؛d^=쐓SWKKU\c<:E7Iqz,1@9L^EM4 p~AI:K)Q 'O\GpI/zAƒhBqH轥yx^&@rxҨKGDѺh@Xrm:B|`~3=C7o;0Ob46Q#Ts"[=l?U݄ 8֋*Quة g&\iW ڹv|;w;p=dYuS{=sṇCx!<{=sṇCx!<{=sṇCx!<{=?!+]':R gˢ,\'#5;?jPTDk뇓Η#O[S7+^=j'&ĩ;;˧ݧwngoξj7/{;cuuL;RW0QCˤ3@3ovv՛|~ _ea/c*(MS4}0odι a?=o+ަyVcX? y|܎~IV!]2Mtc'!;O .1UwSr?JpeP1b~(zfzaNO1"s( %ui MMn6F-+|YUWVW ZνIv]jj.^+('d- iDOej!h2vMC<7(<ɘM!e#jxR"qvx#-,Hܛ7U=v{sK_ Ţieг84zaWJ#u0(LIF;6Sӽy!Zg”I?D D;M,ǫڡ`x[ۘREIl01>L4LpZ& ( &@ G<7!:G!W"D*׾Ծ/]h?uZP=Zo_,V[-jGG~up=ߵO qTvSoZtCAj3^,Xvʃl ^gcrAG!M=ABM7{{W^7;{|\.]zW??|B+(4V<"~s8-STBɟc0g 錖B37̣'3C3YxFޱk`f; ‡)7`i"4{Uq; ,5u`bnmt /ߦsa#SScueS&7{PwzǓF!W} G`/}&R-G`i5;͑Ԧ> uyR;JF&;Ze74 g+[mH)M_*#Rn9WH+s#wӀn;5k< b"t k̨-A#VeIuSyЊ8{ }{J0G>\sM3U˂4 L$ Ǭ{Z̍BM7D#N%'wsO :vh5hVࡏO-sK3d1Wziš9YugtsZ3WStJN* vmw J3X'pBFm'F .scҽ!L)#OG=Zr+.:\x|7i)PBy".atNa*# ywU;Zr׬}Nڷ/݋Ү~u>\m|mrh#U{΍sS8.=kӚL8+K+vt"z<0i3i !r7Qyx{G_y:Do,f}=߯{IYsҚt5d)